Login
← Go Back
Elder Pharmaceuticals
ELDERPHARM · Pharma > Pharmaceuticals & Drugs · MD: Alok Jagdish Saxena · Listing date: April 29, 2000
Stock Price vs Company Growth
5y
1.0%
10y
12.5%
all
11.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 38 0%
N/A
38
Company Overview
Sales
633 Cr
Growth: -28.5%
Profit after Tax
-453 Cr
Growth: 6.3%
Micro Cap
78 Cr
P/S: 0.1x
Industry P/S: 3.2x
Fundamentals
Sales (Cr) ₹ 633
Growth -28.5%
EBITDA -34.1%
P/S 0.1x
Dividend 0.0%
P/E -1.0x
Book Value ₹ 289
PEG Ratio 0.0x
ROE -66.5%
P/B 0.1x
Shareholding Pattern
Institutions
Total
44.25 %
Acraf S.P.A
12.75 %
Citicorp International Finance Corporation
8.42 %
Cbc Bahrain - Fii Equity Account
4.6 %
Development Credit Bank Ltd
3.98 %
Promoters
Total
25.34 %
Indarts Exports Pvt Ltd
7.73 %
Semit Pharmaceuticals & Chemicals Ltd
7.58 %
Akshaya Holdings Pvt Ltd
3.37 %
Jagdish K Saxena
1.97 %
Others
Increase    Decrease    No change
Company Profile Detailed
Elder Pharmaceuticals was incorporated in the year 1983 and commenced operations in 1989. The company is engaged into manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.Elder is one the leading companies in the pharmaceutical formulation market in India. It holds market leader position in three therapeutic segments - Women’s Healthcare, Wound Care and Nutraceuticals.